Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Adherence to Universal Aspirin Compared to Screening Indicated Aspirin for Prevention of Preeclampsia

NCT04797949 is registered in ClinicalTrials.gov with Women and Infants Hospital of Rhode Island as lead sponsor.

NCT NCT04797949
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04797949 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Adherence to Universal Aspirin Compared to Screening Indicated Aspirin for Prevention of Preeclampsia
Lead sponsor
Women and Infants Hospital of Rhode Island
Phase
Phase 4
Overall status
Withdrawn
Start date
March 3, 2021
Completion date
June 1, 2022
Enrollment
0 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

medication adherence, preeclampsia